Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2020, Vol. 34 ›› Issue (5): 132-137.doi: 10.6040/j.issn.1673-3770.0.2020.352

Previous Articles     Next Articles

Expression of cyclin E2 in hypopharyngeal cancer and its clinical significance

  

  • Received:2020-08-05 Published:2020-11-17

PDF (PC)

201

Abstract: Objective This study aims to evaluate the level of expression of cyclin E2 in hypopharyngeal cancer and its relationship with clinical characteristics as well as prognosis. Methods The protein levels of cyclin E2 in tumor tissues and adjacent normal tissues were assessed by immunohistochemistry staining in 50 cases of hypopharyngeal cancer. The relationship between the expression level of cyclin E2 and clinical data was analyzed using the SPSS software. Results Protein levels of cyclin E2 in hypopharyngeal cancer were higher than protein levels of cyclin E2 in normal tissue(Z=-5.764,P=0.000). The cyclin E2 level in tumor tissue correlated with the tumor staging(Z=-1.995, P=0.046)and lymph node metastasis(Z=-2.176, P=0.030). The 5-year survival rates of patients with cyclin E2 positive and negative expression were 40.2% and 81.8%, respectively. Patients with high expression levels of cyclin E2 had a lower survival rate(χ2=6.317, P=0.012). Conclusion The abnormal expression of cyclin E2 protein in tumor tissues indicates that cyclin E2 may be involved in the development of hypopharyngeal cancer and could be a potential diagnostic and prognostic molecular marker.

Key words: Cyclin E2, Hypopharyngeal carcinoma, Database retrieval, Immunohistochemistry, Survival analysis, Prognosis factor

CLC Number: 

  • R739.63
[1] Parfenov M, Pedamallu CS, Gehlenborg N, et al. Characterization of HPV and host genome interactions in primary head and neck cancers[J]. Proc Natl Acad Sci USA, 2014,111:15544-15549. doi: 10.1073/pnas.1416074111.
[2] 黄志刚. CO2激光手术治疗咽喉部肿瘤[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 1-3. doi:10.6040/j.issn.1673-3770.1.2018.022. HUANG Zhigang. Treatment of throat tumors with CO2 laser[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(6): 1-3. doi:10.6040/j.issn.1673-3770.1.2018.022.
[3] Chen NX, Liu K, Liu X, et al. Induction and regulation of the immunoproteasome subunit β5i(PSMB8)in laryngeal and hypopharyngeal carcinoma cells[J]. Med Sci Monit, 2020, 26: e923621-1-e923621-11. doi:10.12659/msm.923621.
[4] Stamatakos M, Palla V, Karaiskos I, et al. Cell cyclins: triggering elements of cancer or not?[J]. World J Surg Oncol, 2010, 8: 111. doi:10.1186/1477-7819-8-111.
[5] Perez-Neut M, Shum A, Cuevas BD, et al. Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells[J]. Oncotarget, 2015, 6(3): 1631-1639. doi:10.18632/oncotarget.2829.
[6] Patch AM, Christie EL, Etemadmoghadam D, et al. Whole-genome characterization of chemoresistant ovarian cancer[J]. Nature, 2015, 521(7553): 489-494. doi:10.1038/nature14410.
[7] Nakayama K, Rahman MT, Rahman M, et al. CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas[J]. Int J Oncol, 2016, 48(2):506-516. doi: 10.3892/ijo.2015.3268.
[8] Liang WW, Guan HY, He XY, et al. Down-regulation of SOSTDC1 promotes thyroid cancer cell proliferation via regulating cyclin A2 and cyclin E2[J]. Oncotarget, 2015, 6(31): 31780-31791. doi:10.18632/oncotarget.5566.
[9] Zhao ZY, Liu JT, Wang CL, et al. MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2[J]. Int J Clin Exp Pathol, 2014, 7(11): 7726-7734.
[10] Chen D, Guo WJ, Qiu ZP, et al. MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer[J]. Cancer Lett, 2015, 362(2): 208-217. doi:10.1016/j.canlet.2015.03.041.
[11] Feng W, Wang C, Liang C, et al. The Dysregulated Expression of KCNQ1OT1 and Its Interaction with Downstream Factors miR-145/CCNE2 in Breast Cancer Cells[J]. Cell Physiol Biochem, 2018, 49(2):432-446. doi: 10.1159/000492978.
[12] Xie L, Li T, Yang LH. E2F2 induces MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts poor overall survival[J]. Eur Rev Med Pharmacol Sci, 2017, 21(9): 2150-2156.
[13] Tormo E, Adam-Artigues A, Ballester S, et al. The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene[J]. Sci Rep, 2017, 7: 41309. doi:10.1038/srep41309.
[14] Schwaederlé M, Daniels GA, Piccioni DE, et al. Cyclin alterations in diverse cancers: Outcome and co-amplification network[J]. Oncotarget, 2015, 6(5): 3033-3042. doi:10.18632/oncotarget.2848.
[15] Kanska J, Zakhour M, Taylor-Harding B, et al. Cyclin E as a potential therapeutic target in high grade serous ovarian cancer[J]. Gynecol Oncol, 2016, 143(1): 152-158. doi:10.1016/j.ygyno.2016.07.111.
[16] Sheldon LA. Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein[J]. Cell Cycle, 2017, 16(21): 2058-2072. doi:10.1080/15384101.2017.1338221.
[17] Geng Y, Michowski W, Chick JM, et al. Kinase-independent function of E-type cyclins in liver cancer[J]. Proc Natl Acad Sci USA, 2018, 115:1015-1020. doi: 10.1073/pnas.1711477115.
[18] Sun Q, Yu R, Wang CF, et al. Correction to: Circular RNA circ-CSPP1 regulates CCNE2 to facilitate hepatocellular carcinoma cell growth via sponging miR-577[J]. Cancer Cell Int, 2020, 20: 293. doi:10.1186/s12935-020-01339-z.
[19] Zhu C, Huang Q, Zhu H. miR-383 Inhibited the Cell Cycle Progression of Gastric Cancer Cells via Targeting Cyclin E2 [J]. DNA Cell Biol, 2019, 38(8):849-856. doi:10.1089/dna.2019.4624.
[20] Yu AQ, Wang ZX, Wu W, et al. Circular RNA CircCCNB1 sponges micro RNA-449a to inhibit cellular senescence by targeting CCNE2 [J]. Aging(Albany NY), 2019, 11(22):10220-10241. doi:10.18632/aging.102449.
[21] Gao P, Wang H, Yu J, et al. miR-3607-3p suppresses non-small cell lung cancer(NSCLC)by targeting TGFBR1 and CCNE2 [J]. PLoS Genet, 2018, 14(12):e1007790. doi:10.1371/journal.pgen.1007790.
[22] Gorjala P, Cairncross JG, Gary RK. p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium [J]. Cell Prolif, 2016, 49(6):698-709. doi:10.1111/cpr.12291.
[23] Xu W, Taranets L, Popov N. Regulating Fbw7 on the road to cancer [J]. Semin Cancer Biol, 2016, 36:62-70. doi:10.1016/j.semcancer.2015.09.005.
[24] Capaldo CT, Koch S, Kwon M, et al. Tight function zonula occludens-3 regulates cyclin D1-dependent cell proliferation[J]. Mol Biol Cell, 2011, 22(10): 1677-85. doi: 10.1091/mbc.E10-08-0677.
[25] Peek GW, Tollefsbol TO. Combinatorial PX-866 and raloxifene decrease Rb phosphorylation, cyclin E2 transcription, and proliferation of MCF-7 breast cancer cells[J]. J Cell Biochem, 2016, 117(7): 1688-1696. doi:10.1002/jcb.25462.
[1] HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30.
[2] XIE Feng, XU Zhenju, WU Ce, LIU Jie, ZANG Chuanshan, ZHANG Longxiao, HAN Min. Clinicopathologic and survival analysis of laryngeal neuroendocrine neoplasm in 26 cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 79-86.
[3] LI Gui, YANG Yanli, LI Donghai, YAN Xiuying. Adult orbital xanthogranulomatous disease with clinicopathological analysis report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 80-85.
[4] LI Yaru, XU Zhenju, WANG Xiaojun, FU Tao, YUAN Yue, WU Ce. Rosai-Dorfman disease of the bilateral neck and nasopharynx: a case report and review of related cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 108-114.
[5] WANG Jingsong, YU Can, ZHANG Xi, DENG Qicheng, XIE Zhuoliang, ZHAO Rui, WEN Bei, LIU Hai. Expression and clinical significance of KRT4 in laryngeal carcinoma and adjacent normal mucosal tissues [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 12-17.
[6] YANG Kaiyan, TANG Fengzhu, QIN Qicai, LI Xuxiang, FENG Dayi, NONG Fengjing, YANG Qiuyun. Expression of abnormal spindle-like microcephaly associated protein in nasopharyngeal carcinoma and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 18-25.
[7] HUANG Hengfeng, MA Kunpeng, YANG Di, ZHANG Lijun, ZHANG Shenglin. Expression and clinical significance of miR-181b-5P and EPB41L3 protein in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 41-46.
[8] CHEN Dongyan, QIAN Ye, WEI Dongmin, LI Wenming, XIA Tongliang, LEI Dapeng, PAN Xinliang. Clinical value of high-frequency ultrasound in the diagnosis of lymph node metastasis in hypopharyngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 18-23.
[9] JIANG Chao, ZHOU Xuanchen, HAN Jie, YUE Zhiyong. Prevalence and prognostic nomogram for IVc stage hypopharyngeal carcinoma patients: a SEER population-based analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 49-54.
[10] CHENG Yao, ZHANG Zhen, YANG Ji, FENG Chengmin, DENG Qicheng, ZHANG Xi, ZHAO Rui, ZHU Xin, WU Junzhi, LIU Hai, DENG Shishan. Expression and clinical significance of CIP2A in hypopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 40-44.
[11] XUE Gang, SUN Xinmin, LIN Xu, WU Jingfang. Expression and clinical significance of the KCNK5 double-pore potassium channel protein in papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 64-69.
[12] WANG Zhongwei, YANG Lin, GUO Ya, SUN Bin, WANG Yali, MA Xiulong, REN Hongtao, BAO Xing. Analysis of the relationship between miR-429 and miR-200C expression and prognosis in patients with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(3): 81-86.
[13] WANG Yayue,SUN Juan. Research progress on differentially-expressed protein kinases and inhibitors in hypopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 119-124.
[14] YUE Jianlin, LIN Yun, JIANG Zhen, LI Xuexin, SUN Ruijie, PAN Xinliang, LIU Dayu. Application of the hemi-tongue root flap for the repair of lateral defects in the pharyngeal cavity [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(1): 63-66.
[15] JIANG Ningning, WANG Penglai, YUAN Changyong, HUANG Xiaofeng, JIANG Changwei, LIU Zongxiang,SUN Tiezhong. The expression and significance of metastasis suppressor 1 protein in tongue squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 64-67.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd